METTL3 and diabetic kidney disease: Previous studies reported that in podocytes of DKD, METTL3 regulated the Notch signaling pathway via m6A modifying TIMP2 in an IGF2BP2-dependent manner, which exerted pro-inflammatory and pro-apoptotic effects [34].